Using a robotic platform to improve hand function in stroke patients
Effect of SynPhNe Physio-neuro Platform on Hand Motor Function Rehabilitation of Acute and Subacute Stroke Patients
NA · National University Hospital, Singapore · NCT05133232
This study is testing whether a robotic system can help stroke patients regain better hand function during their rehabilitation.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 21 Years to 90 Years |
| Sex | All |
| Sponsor | National University Hospital, Singapore (other) |
| Locations | 1 site (Singapore) |
| Trial ID | NCT05133232 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of the SynPhNe physio-neuro platform in enhancing hand motor function rehabilitation for patients who have experienced acute or subacute strokes. The study focuses on providing high-intensity, repetitive, and task-specific rehabilitation through a robotic system, which aims to facilitate neuroplasticity and improve recovery outcomes. Participants will be monitored for progress using this innovative technology, which addresses the limitations of traditional rehabilitation methods that often lack intensity and supervision. The trial seeks to determine if this approach can lead to better functional recovery in stroke survivors.
Who should consider this trial
Good fit: Ideal candidates are adults aged 21-90 who have experienced a hemiparetic stroke within the last four months and have some ability to move their fingers.
Not a fit: Patients with severe cognitive impairments, unstable medical conditions, or other significant neurological diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve hand motor function and independence for stroke patients during their recovery.
How similar studies have performed: While robotic rehabilitation technologies have shown promise, their widespread impact has been limited, making this approach both innovative and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Hemiparetic stroke (haemorrhagic or ischaemic) within 4 months of recruitment; 2. FMA UE less than 55 (out of maximum of 66) but able to extend at least 2 fingers in the affected hand 10 degrees at any joint with pain-free passive range of motion at least 50% in all joints below the elbow; 3. Age 21-90. Exclusion criteria: 1. Cognitive or language impairment resulting in inability to follow instructions or inability to sustain attention for more than 10 minutes or inability to give consent; 2. Poor sitting balance (inability to sustain unsupported sitting for \> 10min) 3. Other orthopaedic or neurological diseases other than stroke affecting the function of the stroke-affected arm; 4. severe pain in the stroke affected upper limb 5. Terminal diseases with expected survival \<1 year 6. Women who are pregnant or breastfeeding 7. Patients who are in medically unstable conditions.
Where this trial is running
Singapore
- Alexandra hospital — Singapore, Singapore (RECRUITING)
Study contacts
- Principal investigator: Effie Chew, MBBS — National University Hospital, Singapore
- Study coordinator: Effie Chew, MBBS
- Email: effie_chew@nuhs.edu.sg
- Phone: 93653542
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stroke